Home > Insider Trading > Filing (0001209191-17-059864)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1609320	Werner Kroll	12544 High Bluff Drive, Suite 200 San Diego CA 92130	Svp, R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-06	7,565	$22.85	10,261	No	4	M	Direct
Common Stock	Disposition	2017-11-06	7,565	$39.50	3,718	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option	Disposition	2017-11-06	7,565	$0.00	7,565	$22.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,918		2024-05-27	No	4	M	Direct

Footnotes

The amount of securities beneficially owned following this transaction include an additional 1,022 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
13,242 shares vested on the second anniversary date of the grant date, May 27, 2016. 6,621 shares vested on the third anniversary date of the grant date, May 27, 2017. 6,620 shares will vest on the fourth anniversary date of the grant date, May 27, 2018.